WeVote

Bill

Bill

SF 850

Limitation modification on optometrist prescribing and administering drugs

2025-2026 Regular Session Introduced by Omar Fateh and 4 co-sponsors

Minnesota bill expands optometrists' authority to prescribe and administer drugs, increasing eye care access but raising clinical training and oversight concerns.

Author added Port
0
WeVote Research Nonpartisan
Bill Summary · SF 850

Legislative bill overview

SF 850 modifies Minnesota's limitations on what drugs optometrists can prescribe and administer to patients. The bill expands the scope of practice for licensed optometrists beyond current restrictions. The specific drugs and administration methods affected would be detailed in the bill's text.

Why is this important

Scope-of-practice laws directly affect patient access to eye care services and whether patients need referrals to ophthalmologists for certain treatments. Expanding optometrist authority could increase convenience and reduce costs for routine eye care, but may raise questions about clinical training and oversight. This reflects ongoing national debates about healthcare workforce utilization.

Potential points of contention

  • Clinical training concerns: Opponents may argue optometrists' educational requirements differ from ophthalmologists' and question whether expanded drug prescribing/administration aligns with their training
  • Patient safety and oversight: Questions about monitoring protocols, adverse event reporting, and liability if complications arise from optometrist-administered drugs
  • Economic competition: Ophthalmologists may resist changes that shift patient care and revenue to optometrists, while optometrist groups support expanded scope

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.